GlassScriptPhysician profile
Kim L Stearns
NPI 1992764203
$80,344.37
in general payments reported to CMS, 2019-2025
17 companies · $8,379 in 2025
The $8,379 reported for 2025 was more than what 75% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,604 · 2020: $2,698 · 2021: $15K · 2022: $25K · 2023: $12K · 2024: $11K · 2025: $8,379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $3,687 · Travel and Lodging: $3,325 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,222.00 |
| Food and Beverage | $3,687.32 |
| Travel and Lodging | $3,324.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,025.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $47,134.73 | 2019-2025 | Biogel Pi, Biogel Pi Ultratouch, Biogel Eclipse |
| Horizon Therapeutics Plc | $24,513.97 | 2019-2022 | |
| Heron Therapeutics, INC. | $2,212.33 | 2020-2023 | Zynrelef |
| Acelrx Pharmaceuticals, INC. | $2,099.59 | 2021 | |
| Stryker Corporation | $1,634.72 | 2019-2025 | Mako, Accolade |
| Forte Bio-Pharma LLC | $917.00 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Steris Corporation | $500.00 | 2019 | |
| Biofire Diagnostics, LLC | $425.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $222.77 | 2022-2025 | Rosa |
| Ovik Health, LLC | $171.10 | 2024 | Coflex Tlc |
| Depuy Synthes Sales INC. | $144.11 | 2019-2022 | |
| Pacira Therapeutics, INC. | $124.21 | 2019 | |
| Linvatec Corporation | $115.22 | 2025 | Biobrace 23mm |
| Organogenesis INC. | $61.94 | 2025 | Puraply Wound Matrix, Affinity |
| Amgen INC. | $35.23 | 2025 | Krystexxa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $19.66 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Globus Medical, INC. | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Stearns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.